SCHEMBL20552585

SCHEMBL20552585

[CH2]CCc1ccc(N=[N+]=[N-])cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP51A1 Q16850 4/20 0.44
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA5A P35218 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ CA5B Q9Y2D0 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ PTGS2 P35354 4/20 0.37
▸ SMO Q99835 2/20 0.34
▸ DNM1 Q05193 1/20 0.34
▸ PSMB8 P28062 1/20 0.33
▸ P2RY6 Q15077 1/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ SCN2A Q99250 1/20 0.33
▸ SCN3A Q9NY46 1/20 0.33
▸ NOX1 Q9Y5S8 1/20 0.33
▸ ALB P02768 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30874461 0.87 CYP51A1 (0.49) CYP51A1CA1CA2CA5ACA9
SCHEMBL19925352 0.83 CYP51A1 (0.46) CYP51A1CA1CA2CA5ACA9
SCHEMBL15290259 0.79 PTGS2 (0.44) CYP51A1CA1CA2CA5ACA9
SCHEMBL26220277 0.79 NOS3 (0.50) CYP51A1CA1CA2CA5ACA9
SCHEMBL13653936 0.79 CA2 (0.46) CYP51A1CA1CA2CA5ACA9
SCHEMBL30906028 0.79 CYP51A1 (0.44) CYP51A1CA1CA2CA5ACA9
SCHEMBL15590856 0.78 CYP51A1 (0.49) CYP51A1CA1CA2CA5ACA9
Hydrochloric Acid SCHEMBL19925268 0.78 NOS3 (0.52) CYP51A1CA1CA2CA5ACA9
SCHEMBL16748959 0.76 CA1 (0.58) CYP51A1CA1CA2CA5ACA9
SCHEMBL14394949 0.76 CYP3A4 (0.49) CYP51A1CA1CA2TP53PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3619216-A1 RAPAMYCIN ANALOGS AS MTOR INHIBITORS Revolution Medicines, Inc. (US) 2020-03-11 — — EP disclosed
WO-2018204416-A1 RAPAMYCIN ANALOGS AS MTOR INHIBITORS Revolution Medicines, Inc. (US) 2018-11-08 — — WO disclosed
Send feedback